Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Antithrombotic action of DX-9065a and enoxaparin compared

March 21, 2001

Combined roxifiban/Innohep has improved safety/efficacy ratio

March 21, 2001

Argatroban enters phase II for ischemic stroke

March 16, 2001

XV-454 compares favorably to abciximab in flow models of thrombosis in vitro

March 16, 2001

Human factor Xa inhibitor JTV-803 is a promising orally active antithrombotic agent

March 14, 2001

Single-injection thrombolytic introduced in the E.U.

March 13, 2001

Emisphere begins phase I evaluation of heparin tablets with SNAD delivery system

March 13, 2001

Heterobicyclic inhibitors of factor Xa synthesized at DuPont as potential new anticoagulants

March 12, 2001

Pharmacokinetics, pharmacodynamics of melagatran examined under different conditions

March 9, 2001

EMD-273040: a new cyclic peptide integrin receptor antagonist

March 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...